Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tillandsia landbeckii

ABSTRACT: Tillandsia landbeckii Genome sequencing

PROVIDER: PRJNA742530 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15015612.fastq.gz	Fastqsanger.gz
	SRR15015612_1.fastq.gz	Fastqsanger.gz
	SRR15015612_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Project description:GBS of Tillandsia landbeckii at cerro Oryabide/Chile

| PRJNA804696 | ENA

null

Project description:Jabbusch/Koch: Identification of genetic variants in Tillandsia landbeckii

| PRJEB71848 | ENA

undefined

Project description:Microbial hotspots related to fog-dependent Tillandsia landbeckii dunes in the Atacama Desert

| PRJEB61789 | ENA

Project description:Tillandsia (subg. Tillandsia) whole-genome data

| PRJNA1052467 | ENA

B04-CRC1211

Project description:Tillandsia landbeckii phyllosphere and laimosphere as refugia for bacterial life in a hyperarid desert environment

| PRJEB57843 | ENA

Tillandsia marconae

Project description:Tillandsia marconae genome sequencing

| PRJNA687917 | ENA

Population genomics of Tillandsia landbeckii

Project description:Population genomics of Tillandsia landbeckii reveals unbalanced genetic diversity and founder effects in the Atacama Desert

| PRJEB35036 | ENA

Tillandsia

Project description:Tillandsia Genome sequencing and assembly

| PRJNA927306 | ENA

Soil bacterial community structure of fog depend Tilladsia landbeckii dunes in the Atacama Desert

Project description:Soil bacterial community structure of fog depend Tillandsia landbeckii dunes in the Atacama Desert Raw sequence reads

| PRJNA751422 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data